Vaishali Pharma Limited
Vaishali Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1990, the company has established itself as a trusted manufacturer and supplier of high-quality pharmaceutical formulations, catering to both domestic and international markets. Specialising in a diverse range of therapeutic segments, Vaishali Pharma is known for its innovative approach to drug development and production. The company’s core offerings include a wide array of generic medicines, which are distinguished by their efficacy and affordability. With a commitment to quality and compliance, Vaishali Pharma has achieved significant milestones, positioning itself as a reliable partner in healthcare. Its dedication to research and development has garnered recognition, making it a respected name in the pharmaceutical landscape.
DitchCarbon Score
How does Vaishali Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vaishali Pharma Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vaishali Pharma Limited's reported carbon emissions
Vaishali Pharma Limited, headquartered in India, currently does not have any reported carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Vaishali Pharma may not yet have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments, it is unclear how Vaishali Pharma aligns with these industry trends. As the company progresses, it may consider adopting frameworks such as the Science Based Targets initiative (SBTi) or participating in climate-related reporting to enhance its environmental accountability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vaishali Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
